Merck & Co. Files 8-K on Financials and Debt

Ticker: MRK · Form: 8-K · Filed: 2024-07-30T00:00:00.000Z

Sentiment: neutral

Topics: financial-condition, debt, filing

Related Tickers: MRK

TL;DR

Merck filed an 8-K detailing its financial condition and various debt notes due between 2024 and 2054.

AI Summary

Merck & Co., Inc. filed an 8-K on July 30, 2024, to report on its results of operations and financial condition. The filing includes financial statements and exhibits, detailing various debt instruments such as notes due in 2024, 2026, 2032, 2034, 2036, 2037, 2044, and 2054.

Why It Matters

This filing provides an update on Merck's financial health and its outstanding debt obligations, which are crucial for investors to assess the company's financial stability and future borrowing capacity.

Risk Assessment

Risk Level: low — This is a routine financial filing and does not indicate any immediate or significant risks for the company.

Key Numbers

Key Players & Entities

FAQ

What is the purpose of this 8-K filing by Merck & Co., Inc.?

The purpose of this 8-K filing is to report on Merck & Co., Inc.'s Results of Operations and Financial Condition, and to file Financial Statements and Exhibits.

When was this 8-K filing submitted to the SEC?

This 8-K filing was submitted to the SEC on July 30, 2024.

What types of financial instruments are mentioned in the filing related to Merck's debt?

The filing mentions various notes with different interest rates and maturity dates, including notes due in 2024, 2026, 2032, 2034, 2036, 2037, 2044, and 2054.

What is Merck & Co., Inc.'s fiscal year end?

Merck & Co., Inc.'s fiscal year end is December 31.

What is Merck & Co., Inc.'s primary business classification according to the SIC code?

Merck & Co., Inc.'s Standard Industrial Classification (SIC) code is 2834, which corresponds to Pharmaceutical Preparations.

From the Filing

0001104659-24-083722.txt : 20240730 0001104659-24-083722.hdr.sgml : 20240730 20240730064150 ACCESSION NUMBER: 0001104659-24-083722 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 17 CONFORMED PERIOD OF REPORT: 20240730 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240730 DATE AS OF CHANGE: 20240730 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Merck & Co., Inc. CENTRAL INDEX KEY: 0000310158 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 221918501 STATE OF INCORPORATION: NJ FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-06571 FILM NUMBER: 241154319 BUSINESS ADDRESS: STREET 1: 2000 GALLOPING HILL ROAD CITY: KENILWORTH STATE: NJ ZIP: 07033 BUSINESS PHONE: 908-740-4000 MAIL ADDRESS: STREET 1: 2000 GALLOPING HILL ROAD CITY: KENILWORTH STATE: NJ ZIP: 07033 FORMER COMPANY: FORMER CONFORMED NAME: Merck & Co. Inc. DATE OF NAME CHANGE: 20091103 FORMER COMPANY: FORMER CONFORMED NAME: SCHERING PLOUGH CORP DATE OF NAME CHANGE: 19920703 8-K 1 tm2420272d1_8k.htm FORM 8-K false 0000310158 0000310158 2024-07-30 2024-07-30 0000310158 us-gaap:CommonStockMember 2024-07-30 2024-07-30 0000310158 mrk:Sec0.500NotesDue2024Member 2024-07-30 2024-07-30 0000310158 mrk:Sec1.875NotesDue2026Member 2024-07-30 2024-07-30 0000310158 mrk:Sec3.250NotesDue2032Member 2024-07-30 2024-07-30 0000310158 mrk:Sec2.500NotesDue2034Member 2024-07-30 2024-07-30 0000310158 mrk:Sec1.375NotesDue2036Member 2024-07-30 2024-07-30 0000310158 mrk:Sec3.500NotesDue2037Member 2024-07-30 2024-07-30 0000310158 mrk:Sec3.700NotesDue2044Member 2024-07-30 2024-07-30 0000310158 mrk:Sec3.750NotesDue2054Member 2024-07-30 2024-07-30 iso4217:USD xbrli:shares iso4217:USD xbrli:shares       UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C.  20549   FORM  8-K   CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934   Date of Report (Date of earliest event reported) July 30, 2024 ( July 30, 2024 )   Merck & Co., Inc. (Exact name of registrant as specified in its charter)   New Jersey (State or other jurisdiction of incorporation)   1-6571 (Commission File Number)   22-1918501 (I.R.S. Employer Identification No.)   126 East Lincoln Avenue , Rahway , NJ (Address of principal executive offices)   07065 (Zip Code)   (Registrant’s telephone number, including area code) ( 908 ) 740-4000   Not Applicable (Former name, former address and former fiscal year, if changed since last report.)   Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:   ¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))   Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).   Emerging growth company   ¨   If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.   ¨   Securities registered pursuant to Section 12(b) of the Act:   Title of each class   Trading Symbol(

View on Read The Filing